A study for a 23 year old man who takes Clonazepam, Adderall 20, Tramadol, Ganga - from FDA reports


Summary

212 males aged 23 (±5) who take the same drugs are studied. This is a personalized study for a 23 year old male patient who has Anxiety, Attention Deficit Hyperactivity Disorder (adhd), Fibromyalgia, Pain. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On May, 19, 2017

212 males aged 23 (±5) who take Clonazepam, Adderall 20, Tramadol, Ganga are studied.


Number of reports submitted per year:

Clonazepam, Adderall 20, Tramadol, Ganga for a 23-year old man.

Information of the patient in this study:

  • Age: 23
  • Gender: male
  • Conditions: Anxiety, Attention Deficit Hyperactivity Disorder (adhd), Fibromyalgia, Pain
  • Drugs taken:
    • Clonazepam (clonazepam)
    • Adderall 20 (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate)
    • Tramadol (tramadol hydrochloride)
    • Ganga (marijuana)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  • drug abuse and dependence
  • drug ineffective
  • breathing - slowed or stopped
  • burning sensation
  • cardiac arrest
  • chest pain
  • hyperhidrosis
  • heart palpitations
  • pruritus generalised
  • ocular discomfort
1 - 6 months:
  • weight decreased
  • eyes - bulging
  • anger
  • overdose
  • abdominal discomfort
  • abnormal behavior
  • vasodilatation
  • aggression
  • drug abuse and dependence
  • dry mouth
6 - 12 months:
  • therapeutic response decreased
  • drug dependence
  • psychotic disorder
1 - 2 years:
n/a
2 - 5 years:
  • high blood cholesterol
  • heart palpitations
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  • drug abuse and dependence
  • overdose
  • completed suicide
  • death
  • high blood pressure
  • drug dependence
  • cardio-respiratory arrest
  • arrhythmias
  • intentional overdose
  • weight decreased

Top conditions involved for these people *:

  • Cataplexy (8 people, 3.77%)
  • Schizophrenia (6 people, 2.83%)
  • Drug Abuse (6 people, 2.83%)
  • Drug Dependence (5 people, 2.36%)
  • Relapsing-Remitting Multiple Sclerosis (4 people, 1.89%)

Top co-used drugs for these people *:

  • Xyrem (17 people, 8.02%)
  • Alprazolam (17 people, 8.02%)
  • Neurontin (13 people, 6.13%)
  • Zolpidem (12 people, 5.66%)
  • Morphine (12 people, 5.66%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

What are the drugs?

What are the conditions?

Related studies: